Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres

Clin Exp Dermatol. 2023 Nov 16;48(12):1376-1378. doi: 10.1093/ced/llad277.
No abstract available

MeSH terms

  • Humans
  • Mycosis Fungoides* / drug therapy
  • Sezary Syndrome* / drug therapy
  • Skin Neoplasms* / drug therapy
  • Tertiary Care Centers

Substances

  • dupilumab